OS Therapies Inc
OSTXDrugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Next month
Market Overview
Stock performance and key metrics
1 upcoming, 0 past
No drugs found in this phase.
Prevention or delay of recurrence in fully resected, pulmonary metastatic osteosarcoma
1 drug in this indication
osteosarcoma
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Full breakdown — the signals behind the verdict
Frequently asked questions
When is OS Therapies Inc's next FDA catalyst?→
OS Therapies Inc's (OSTX) next tracked catalyst is a Earnings expected November 13, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track OSTX biotech catalysts?→
Add OSTX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow OS Therapies Inc's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.